ArticlePloS one2025
Dermal formulation based on carbopol and Gum Arabic improves skin retention of indomethacin.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Dermal Formulation Incorporating Isoconazole Nitrate Nanoparticles Offers High Absorption into Skin and Antimicrobial Effect AgainstPharmaceutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Top-down approaches efficiently convert hydrophobic drugs into nanoparticles, and the selection of appropriate additives is critical for successful nanoparticle formulation. Methylcellulose is an additive capable of reducing the drug particle size to less than 200 nm using the wet bead milling method, a breakdown method, and a dermal gel containing indomethacin (IMC) nanocrystal formulated with methylcellulose, which achieved high skin absorption. In this study, we focused on gum arabic (GA) as an alternative additive to methylcellulose and demonstrated whether formulations (carbopol gels) containing IMC nanocrystals with GA for dermal application (IMC-NP@GCgel) enhanced the local and systemic absorption of IMC. The particle size was significantly reduced by bead milling with GA, and the mean particle size of the IMC-NP@GCgel was 40-200 nm. The drug release and skin permeability from IMC-NP@GCgel was higher than those from carbopol gels containing the IMC microcrystals (mean particle size was 15.6 µm, IMC-MP@GCgel). In addition, IMC levels in the skin tissue of rats treated with the IMC-NP@GCgel were higher than those of rats treated with the IMC-MP@GCgel. However, the plasma IMC levels did not differ between the IMC-MP@GCgel- and IMC-NP@GCgel-treated rats. We successfully designed IMC nanocrystals using GA instead of methylcellulose. Moreover, we found that the addition of GA supported the absorption of IMC nanocrystals and enhanced the skin retention of the drug without increasing plasma IMC levels. These results provide useful information for the development of dermal formulations based on nanocrystals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.